‹ RARE latest research

RARE (Ultragenyx Pharmaceutical Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed RARE on 1 market night between April 21, 2026 and April 21, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

1 calls 1 BUY · 0 HOLD · 0 SELL BUY calls up after 20 trading days: 0 of 1
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
April 21, 2026 BUY $25.06 $28.50 / $22.78 +1.8% -6.8%
Based on the potential swing to the next resistance level.

Related stocks

XERS Xeris Biopharma Holdings, InSNDX Syndax Pharmaceuticals, Inc.SGRY Surgery Partners, Inc.RXRX Recursion Pharmaceuticals, IREPL Replimune Group, Inc.PHAT Phathom Pharmaceuticals, Inc

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated November 4, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.